Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists

作者: Francesco Sinigaglia , Paola Panina-Bordignon , Michael Klaus , Werner Bollag

DOI:

关键词:

摘要: Retinoids with retinoid receptor antagonistic activity, pharmaceutically acceptable salts and hydrolyzable esters thereof, have been found efficacious in treating T-helper cell type 2 (Th2)-mediated immune diseases, such as immunoglobulin E (IgE)-mediated allergic diseases.

参考文章(24)
Shigeki Hibi, Makoto Asada, Isao Yamatsu, Takayuki Hida, Aichi Ogasawara, Mitsuo Nagai, Ieharu Hishinuma, Junichi Nagakawa, Hiroyuki Yoshimura, Koichi Kikuchi, Norimasa Miyamoto, Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar). ,(1993)
Douglas S. Robinson, A. Barry Kay, Role of Th1 and Th2 cells in human allergic disorders. Chemical Immunology. ,vol. 63, pp. 187- 203 ,(1996) , 10.1159/000319486
Allen John Lovey, Peter Mohr, Michael Rosenberger, Michael Klaus, Retinoic acid x-receptor ligands ,(1995)
Margherita T. Cantorna, Faye E. Nashold, Colleen E. Hayes, Vitamin A deficiency results in a priming environment conducive for Th1 cell development European Journal of Immunology. ,vol. 25, pp. 1673- 1679 ,(1995) , 10.1002/EJI.1830250629